Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They could get REGEN now at a bargain price of $15-20 a share.They could pay cash or stock.At that point the preferred shares would also get paid off.Win win for most everyone.
This is the PR that I was referring to.
https://finance.yahoo.com/news/regen-biopharma-initiates-nr2f6-t-133000324.html
They did mentin that clinical trials would be performed at the John Wayne Cancer Center.This isnt happening as fast as some people would like,but they are on track.FDA approval for this stage is a formality.The real test of the science is in clinical trials.This year there have been a couple of spectactular failures at various stages of trials,so there is a minefield ahead but its the scientists involved in this company that will dictate the path.
As for Landers he has been on board a month and a few weeks.I suspect the funding for trials is ready to go conringent on approval.
Since the FDA requested the safety study I am hoping we would get an expedited approval much sooner than the 30 day period.The safety study didnt produce any issues we should get a pro forma approval to begin trials.
Nice volume and a green close at the high of the day.Can't beat that with a stick.
We havent seen this much volume in awhile.This may truly be a memorable Thanksgiving.
Post stickied ! Thanks for catching the PR !!
Volume or rather the lack of,tells the tale of the trading day.People are holding tightly.At this point shares are in strong hands and are awaiting news from the FDA.The required share price to uplist to Nasdaq is $4.It is based on the bid.Clearly we arent there yet,but could be once we have FDA approval.Just an FYI.
More prefered shares would be nice and wont add to the o/s.
As today is a Federal holiay I dont expect FDA news,but I would think we should hear something this week.They wanted a safety study and that was accomplished,so whats the hold up ?
Maybe he has cancer and is stepping aside so he can take part in the clinicals ?
The way the day started I thought we would drop below .10 pps.But its not about the start but how the day ends and with the shocking news about Dr Ichim I think RGBP held up well.
Usually a company will release bad news followed by good news.I hope that we would see a pr relating to FDA approval/clinical trials.
Lander was introduced as the incoming President and now he is also Chief Science Officer ?
All well and good but why resign from the Board ?Is his sister staying with RGBP ?
Check the date its 4 Nov 2014
I agree about the pr's being nice,but not what the market is looking for.What it does do long term is to lay the foundation for an income stream of patent licensing for Big Pharma wanting to get into this market.
I think we will have a significant pr tomorrow.This buzz then would set the stage for clinical trials and investor funding.A pps at $4-8 would help the company immensely.
Alrighty.I will delete the duplicate post to keep things tidy.:)
Bad link
Huge volume today.I will go out on a limb and say we will close green.
I guess I jumped the gun on the pr.SEND was what I was thinking about.Sorry.
http://www.criver.com/files/pdfs/pcs/general/send-e-guide.aspx
I suspect that uplisting is in the cards as well.
We saw a pr stating that CRL submitted the results electronically to the FDA.
Its not common in my experience.
The 8k doesnt mean that the company WILL issue the max number of shares.I see this possibly as a poison pill.
http://legal-dictionary.thefreedictionary.com/Poison+Pill
If a material event occurs the company is obliged to report it.The ball is in the FDA's court,while waiting for that I suspect the company will be lining up funding for clinical trails and probably safety studies for the rest of the pipeline.
Finally the results are released!! I suspect FDA approval will happen this week for hema.
While it isnt RGBP,it is an interesting filing with its share structure,including a Trust that I was unaware of.
Not much volume either.News has to be pretty close.
Stem Meeting on the Mesa was 7-9 Oct.Did anyone see a PR ?
Liver cancer is already a busy field.I would like to see brain cancer or prostate cancer being targeted.
For the greatest impact,announcing FDA approval prior to the Meeting on the Mesa would create buzz at the conference and would of course send the pps into dollar land.
Super post Jack !!
The only reason you work in Qatar is for the big money.The only way he gives that up is for a big payday.
What has caused the sudden buying today ?
I wasnt aware of that.Thanks
The initial report out of Charles River was that the mice had no adverse reaction to dosing that was equivalent to what a human would receive.I do not think we will get a bad report,rather the delay is probably at the FDA.Its also possible that testing would have been done with the other IND products as well,so at the end we could see approvals for the pipeline.
They wouldnt issue a pr unless it was scheduled.The timing of an FDA approval with the conference would be awesome.
http://www.waff.com/story/30130240/regen-biopharma-inc-director-of-molecular-therapeutics-to-speak-at-stem-cell-conference-regarding-leukemia-research-being-conducted-by-the-company
ALSO here is the link of the participants AND RGBP IS listed.
http://stemcellmeetingonthemesa.com/attendees/
Back to .20 EOD,unless we get FDA news.Then it should explode.